NASD · Healthcare · Diagnostics & Research · USA
Sotera Health Co is a mid cap company (market value between $2 billion and $10 billion) in the Diagnostics & Research industry.
Sotera Health supplies sterilization solutions and laboratory testing services to medical device, pharmaceutical, and food manufacturers globally. Through Sterigenics, the company offers terminal sterilization using gamma irradiation, EO processing, and E-beam technology across facilities in multiple countries. Nordion produces cobalt-60 sources and gamma irradiation systems utilized in sterilization and cancer treatment worldwide.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Sotera Health Co stock.
Overvalued: intrinsic value $10.14 per share, market price $16.05, margin of safety -58.3% (as of 2026-11-17).
Discounting its cash flows at 10.4% values the shares at $10.14; the price of $16.05 is 58% above that value.
17 more funds hold it; the full list is part of the paid plan.
All 44 Diagnostics & Research stocks
3 more in this industry show a wider margin of safety.
SHC is overvalued (as of the 2026-11-17 close). Discounting its cash flows at 10.4% values the shares at $10.14; the price of $16.05 is 58% above that value.
$10.14 per share (as of the 2026-11-17 close), against a market price of $16.05. That is a margin of safety of -58.3%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.